Close
AI in Healthcare & Pharma Summit Boston 2026

New Nymalize Oral Solution 10 mL Unit Dose for the Treatment of Subarachnoid Hemorrhage launched by Arbor Pharma

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, announced today that Nymalize® (nimodipine) Oral Solution will now be available in a 10 mL (30...

Anti-Blindness Effort Pioneered by NewYork-Presbyterian/Columbia University Medical Center’s Tele-Ophthalmology Unit

Presbyterian/Columbia University Medical Center (CUMC) recently unveiled a state-of-the-art mobile testing unit in a push to reduce blindness-causing eye diseases across the city. The...

Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that the United States Food and Drug Administration (“FDA”) has granted orphan designation to omaveloxolone...

2017 Scientist Award For Best New Clinical Laboratory Product received by Agilent

Agilent Technologies Inc. has received a 2017 Scientists' Choice Award for Best New Clinical Laboratory Product: the IQFISH Panel for Lung Cancer. The IQFISH...

Charter Medical Announces Completion of Major Rebranding Initiative

Charter Medical Ltd., a globally recognized manufacturer of products for the regenerative medicine, blood management, and bioprocessing industries, unveiled a modernized identity this morning...

Sanofi Receives Tentative FDA Approval of Admelog 100 Units/mL

Sanofi announced that the U.S. FDA granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin analog. Admelog is indicated...

FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma

Genentech, a member of the Roche Group , announced that the U.S. FDA has accepted the company’s supplemental Biologics License Application (sBLA) and granted...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...